What does GlucoTrack, Inc. do?
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent…
What is GlucoTrack, Inc.'s P/E and P/B ratio?
GlucoTrack, Inc. has a P/E ratio of -0.0 and a P/B ratio of -0.35.
What is GlucoTrack, Inc.'s debt-to-equity ratio?
GlucoTrack, Inc. has a debt-to-equity ratio of 1.22.
How much does GlucoTrack, Inc. owe compared with what it owns?
GlucoTrack, Inc. owes $2.16 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is GlucoTrack, Inc.'s Positivity rank?
GlucoTrack, Inc. is ranked #6,410 of 6,774 companies globally and #3,674 of 4,000 in United States on PositoAI, with a Positivity Score of -18,913.
Does GlucoTrack, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. GlucoTrack, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 15 May 2026). It has no yellow flags.
Where can I read the latest news about GlucoTrack, Inc.?
Recent headlines about GlucoTrack, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does GlucoTrack, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of GlucoTrack, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.